SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 232 filers reported holding SEATTLE GENETICS INC in Q4 2015. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,188,000 | +10.5% | 17,907 | -12.8% | 0.72% | +11.6% |
| Q1 2018 | $1,075,000 | -11.5% | 20,543 | -9.6% | 0.64% | -9.2% |
| Q4 2017 | $1,215,000 | -8.5% | 22,719 | -6.9% | 0.71% | -5.0% |
| Q3 2017 | $1,328,000 | +2.6% | 24,405 | -2.4% | 0.75% | +5.4% |
| Q2 2017 | $1,294,000 | -13.4% | 25,017 | +5.2% | 0.71% | -17.5% |
| Q1 2017 | $1,495,000 | +6.7% | 23,782 | -10.4% | 0.86% | -1.0% |
| Q4 2016 | $1,401,000 | -39.7% | 26,557 | -38.3% | 0.87% | -41.4% |
| Q3 2016 | $2,325,000 | +0.4% | 43,050 | -24.9% | 1.48% | -1.3% |
| Q2 2016 | $2,316,000 | -1.7% | 57,305 | -14.6% | 1.50% | -0.4% |
| Q1 2016 | $2,355,000 | -23.9% | 67,119 | -2.7% | 1.51% | -17.1% |
| Q4 2015 | $3,095,000 | +15.2% | 68,954 | -1.1% | 1.82% | +19.6% |
| Q3 2015 | $2,687,000 | -24.1% | 69,689 | -4.7% | 1.52% | -4.6% |
| Q2 2015 | $3,540,000 | -3.9% | 73,144 | -29.8% | 1.59% | +0.2% |
| Q1 2015 | $3,683,000 | +1254.0% | 104,175 | +1129.9% | 1.59% | +1105.3% |
| Q4 2014 | $272,000 | – | 8,470 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |